Animal experiments demonstrate that angiotensin II (Ang II) activates NF-κB and STAT3 signaling pathways by binding to AT1 receptors (AT1R), inducing CRC cell EMT and enhancing their infiltrative and migratory abilities (155). The gene discussed is AGT; the disease is colorectal carcinoma.